PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · 2024
DOI: 10.1089/mab.2024.0003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 2024. Verfasst von Tsunenori Ouchida und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Miyagi, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Ursidae. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Miyagi, Japan.
ORCID-Profile: Yukinari Kato
Zitieren
APA
Ouchida, T., Li, G., Suzuki, H., Yanaka, M., Nakamura, T., Handa, S., Tanaka, T., Kaneko, M. K., & Kato, Y. (2024). PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. https://doi.org/10.1089/mab.2024.0003
Vancouver
Ouchida T, Li G, Suzuki H, Yanaka M, Nakamura T, Handa S, et al. PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2024. doi:10.1089/mab.2024.0003
BibTeX
@article{Ouchida2024,
author = {Ouchida, Tsunenori and Li, Guanjie and Suzuki, Hiroyuki and Yanaka, Miyuki and Nakamura, Takuro and Handa, Saori and Tanaka, Tomohiro and Kaneko, Mika K and Kato, Yukinari},
title = {PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody},
journal = {Monoclonal Antibodies in Immunodiagnosis and Immunotherapy},
year = {2024},
doi = {10.1089/mab.2024.0003}
}
EUVIMED